Australia Veterinary Cardiology Market Size & Outlook

Name: Australia Veterinary Cardiology Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The veterinary cardiology market in Australia is expected to reach a projected revenue of US$ 151.9 million by 2033. A compound annual growth rate of 10.35% is expected of Australia veterinary cardiology market from 2026 to 2033.

Animal Health
- Animal Pharmaceuticals & Biotechnology
  - Veterinary cardiology Market Outlook

Australia veterinary cardiology animal type outlook (Revenue, USD million, 2021-2033)
- Companion Animals
  - Dogs
  - Cats
  - Horses
  - Others
- Production Animals
  - Cattle
  - Poultry
  - Others
Australia veterinary cardiology product outlook (Revenue, USD million, 2021-2033)
- Pharmaceuticals
  - Pimobendan
  - Spironolactone and benazepril hydrochloride
  - Others
  - Oral
  - Injectable
- Diagnostics
  - Physical exam
  - Chest X-rays
  - Electrocardiogram (ECG)
  - Others
Australia veterinary cardiology indication outlook (Revenue, USD million, 2021-2033)
- Congestive Heart Failure
- Myocardial (Heart Muscle) Disease
- Arrhythmias
- Others
Australia veterinary cardiology end use outlook (Revenue, USD million, 2021-2033)
- Veterinary Hospitals & Clinics
- Others
Australia veterinary cardiology distribution channel outlook (Revenue, USD million, 2021-2033)
- Hospital/ Clinic Pharmacy
- Retail
- E-Commerce

Australia Veterinary Cardiology Market Size & Outlook

Data Tree

Sign up - it's easy, and free!